News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–42
Matches
42
Sources here
2
Companies here
1
Search results Stored financial headlines

Active search

42 matching headlines

Ticker or company: LXRXMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

TradingKey Earnings Main company 🇺🇸 United States

Lexicon Pharmaceuticals Inc (LXRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution — TradingKey

The TradingKey article on Lexicon Pharmaceuticals Inc (LXRX) indicates that the company's revenue breakdown by business segments and regions has not yet been disclosed. The page provides basic stock information, including the current price, market cap, and a note that relevant financial data is …

LXRX main company
Sharemaestro market context Trend signal active 52 weeks +95.0% LXRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Lexicon Pharmaceuticals Inc (LXRX) Earnings Forecast: Future EPS & Revenue Growth Estimates

Lexicon Pharmaceuticals Inc (LXRX) has an earnings forecast score of 7.60, placing it 282 out of 386 in the Biotechnology & Medical Research industry. Analysts have an average price target of $1.90, with forecasts ranging from $1.00 to $6.00, and most analysts recommend a …

LXRX main company
Sharemaestro market context Trend signal active 52 weeks +95.0% LXRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

Lexicon Pharmaceuticals Inc (LXRX) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Lexicon Pharmaceuticals Inc (LXRX), highlighting its volatility and financial risk. The company has a beta of 1.06, indicating higher sensitivity to market movements. Its risk assessment score is 3.74, placing it 114th out of 386 in the …

LXRX main company
Sharemaestro market context Trend signal active 52 weeks +95.0% LXRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

LXRX|Lexicon Pharmaceuticals Inc|Price:2.290|Chg%:-0.010

Lexicon Pharmaceuticals Inc. (LXRX) is a biopharmaceutical company focused on developing therapies for neuropathic pain, obesity, and cardiometabolic disorders, and commercializing INPEFA for heart failure and type 2 diabetes. The company's fundamentals are robust with high growth potential, and its stock is considered fairly …

LXRX main company
Sharemaestro market context Trend signal active 52 weeks +95.0% LXRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Lexicon Pharmaceuticals Inc (LXRX) Financial Health: Profitability & Balance Sheet Analysis

Lexicon Pharmaceuticals Inc (LXRX) currently holds a strong financial health score of 8.90, ranking 22nd in its industry, indicating stable financial status and high operating efficiency. The company recently reported significant growth, with its latest quarterly revenue climbing 1572.11% year-over-year and net profit increasing …

LXRX main company
Sharemaestro market context Trend signal active 52 weeks +95.0% LXRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingView Earnings Main company 🇺🇸 United States

Price to earnings forward of Lexicon Pharmaceuticals, Inc. – NASDAQ:LXRX

This article provides financial information for Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX), specifically focusing on its forward price-to-earnings ratio. The content is primarily a data page from TradingView, offering an overview of the company's financials without detailed analysis.

LXRX main company
Sharemaestro market context Trend signal active 52 weeks +95.0% LXRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context